Synthesis and evaluation of N-acylsulfonamide and N-acylsulfonylurea prodrugs of a prostacyclin receptor agonist
Authors:
- Tetsuo AsakiTATetsuo Asaki
- 1 December 2007
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 15 (24) , 7720-7725
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Structure–activity studies on diphenylpyrazine derivatives: A novel class of prostacyclin receptor agonistsBioorganic & Medicinal Chemistry, 2007
- 2-{4-[(5,6-Diphenylpyrazin-2-yl)(isopropyl)amino]butoxy}-N-(methylsulfonyl)acetamide (NS-304), an Orally Available and Long-Acting Prostacyclin Receptor Agonist ProdrugThe Journal of Pharmacology and Experimental Therapeutics, 2007
- Treatment of Pulmonary Arterial HypertensionNew England Journal of Medicine, 2004
- A simple stereoselective synthesis and biological evaluation of FR181157: orally active prostacyclin mimeticBioorganic & Medicinal Chemistry Letters, 2003
- A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary HypertensionNew England Journal of Medicine, 1996
- Molecular design of novel PGI2 agonists without PG skeleton. IVBioorganic & Medicinal Chemistry Letters, 1995
- Nonprostanoid prostacyclin mimetics. 5. Structure-activity relationships associated with [3-[4-(4,5-diphenyl-2-oxazolyl)-5-oxazolyl]phenoxy]acetic acidJournal of Medicinal Chemistry, 1993
- Nonprostanoid prostacyclin mimetics. 2. 4,5-diphenyloxazole derivatives.Journal of Medicinal Chemistry, 1992
- Prostacyclin and vascular function: Implications for hypertension and atherosclerosisPharmacology & Therapeutics, 1990
- An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregationNature, 1976